206 related articles for article (PubMed ID: 24854552)
21. Different mechanisms of cisplatin resistance development in human lung cancer cells.
Okamoto K; Saito Y; Narumi K; Furugen A; Iseki K; Kobayashi M
Biochem Biophys Res Commun; 2020 Oct; 530(4):745-750. PubMed ID: 32782152
[TBL] [Abstract][Full Text] [Related]
22. [Effects of shRNA on Cisplatin-resistant Non-small Cell Lung Cancer Cell A549 via Silencing
He L; Du ZD; Wang Y; Meng RQ; Zhao WW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):312-319. PubMed ID: 32543135
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
[TBL] [Abstract][Full Text] [Related]
24. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
25. [Curcumin promoted the apoptosis of cisplain-resistant human lung carcinoma cells A549/DDP through down-regulating miR-186*].
Tang N; Zhang J; Du Y
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):301-6. PubMed ID: 20677554
[TBL] [Abstract][Full Text] [Related]
26. Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF-kappaB pathway activation in lung cancer.
Thu KL; Pikor LA; Chari R; Wilson IM; Macaulay CE; English JC; Tsao MS; Gazdar AF; Lam S; Lam WL; Lockwood WW
J Thorac Oncol; 2011 Sep; 6(9):1521-9. PubMed ID: 21795997
[TBL] [Abstract][Full Text] [Related]
27. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
28. Knockdown of circ‑PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR‑429/FOXK1 signaling axis.
Cao L; Zhou X; Ding X; Gao D
Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34328193
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic effects of sorafenib on the A549/DDP human lung adenocarcinoma cell line in vitro.
Chen XQ; Wang YL; Li ZY; Lin TY
Mol Med Rep; 2014 Jul; 10(1):347-52. PubMed ID: 24788469
[TBL] [Abstract][Full Text] [Related]
30. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
[TBL] [Abstract][Full Text] [Related]
31. Increased sensitivity of human lung adenocarcinoma cells to cisplatin associated with downregulated contactin-1.
Zhang R; Yao W; Qian P; Li Y; Jiang C; Ao Z; Qian G; Wang C; Wu G; Li J; Ji F; Xu J
Biomed Pharmacother; 2015 Apr; 71():172-84. PubMed ID: 25960233
[TBL] [Abstract][Full Text] [Related]
32. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
[TBL] [Abstract][Full Text] [Related]
33. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
[TBL] [Abstract][Full Text] [Related]
34. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
[TBL] [Abstract][Full Text] [Related]
35. [Examination of resistance of lung adenocarcinoma cells to cisplatin by technetium-99m methoxyisobutyl isonitrile].
Hu S; Hu CP; Liang CH
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1493-8. PubMed ID: 16061030
[TBL] [Abstract][Full Text] [Related]
36. [Effect of Src tyrosine kinase inhibition on the drug-resistance as well as MDR1 and LRP expression of the human cis-platinum-resistant lung cancer cell line A549/DDP].
Lv J; Tian Y
Zhongguo Fei Ai Za Zhi; 2012 Sep; 15(9):501-6. PubMed ID: 22989452
[TBL] [Abstract][Full Text] [Related]
37. [The roles of holothurian glycosaminoglycan combined with cisplatin on proliferation and chemotherapeutic response in A549 human lung adenocarcinoma cell].
Jin Q; Zhu XH; Lin CZ; Zhang H; Cao YW; Ding XQ; Lyu ZH
Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):252-257. PubMed ID: 29730910
[No Abstract] [Full Text] [Related]
38. Bcl-2 small interfering RNA sensitizes cisplatin-resistant human lung adenocarcinoma A549/DDP cell to cisplatin and diallyl disulfide.
Huang Z; Lei X; Zhong M; Zhu B; Tang S; Liao D
Acta Biochim Biophys Sin (Shanghai); 2007 Nov; 39(11):835-43. PubMed ID: 17989874
[TBL] [Abstract][Full Text] [Related]
39. Curcumin reverses cis-platin resistance and promotes human lung adenocarcinoma A549/DDP cell apoptosis through HIF-1α and caspase-3 mechanisms.
Ye MX; Zhao YL; Li Y; Miao Q; Li ZK; Ren XL; Song LQ; Yin H; Zhang J
Phytomedicine; 2012 Jun; 19(8-9):779-87. PubMed ID: 22483553
[TBL] [Abstract][Full Text] [Related]
40. [Effects of bevacizumab and cisplatin on human lung adenocarcinoma A549/DDP xenografts in nude mice].
Dai M; Luo RC; Zheng DY; Lü CW; Ding XM
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1402-5. PubMed ID: 17884788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]